Johnson & Johnson testing COVID-19 vaccine on teens

Johnson & Johnson testing COVID-19 vaccine on teens

Johnson & Johnson testing COVID-19 vaccine on teenagers

WHAT ABOUT OTHER KIDS? >> I THICK IT’S IMPORTANT TO START LETTING KIDS HAVE SOMETHING CLOSER TO NORMAL ACTIVITIES. BE IT RETURNING IN PERSON TO SCHOOL, DOING SPORTS AND SOCIAL ACTIVITIES AS LONG AS THEY ARE CAREFUL. KIM: CDC GUIDELINES ARE CLEAR FOR THOSE VACCINATED. THEY CAN BE INDOORS IN SMALL GROUPS WITH NO MASKS. BUT THERE IS NO VACCINE APPROVED FOR KIDS UNDER 16. SO WHAT ABOUT INDOOR PLAY DATES? >> IT’S PROBABLY STILL A GOOD IDEA TO KEEP THE KIDS MASKS — MASKED INSIDE. >> OUTSIDE IS THE SAFEST BET. DOCTORS SAY IT’S OK TO TAKE YOUR KIDS TO STORES AS LONG AS EVERYONE IS WEARING MASKS. >> I WOULD CONTINUE TO BE CAREFUL INSIDE OF RESTAURANTS, ESPECIALLY CROWDED RESTAURANTS, BECAUSE THERE COULD BE THE POTENTIAL OF DISEASE. >> THE KEY TO BEING OUT AND ABOUT IS THAT THERE ARE MANY DIFFERENT WAYS TO REDUCE THE CHANCES OF GETTING COVID. SO PHYSICAL DISTANCING, WEARING A MASK, HAND HYGIENE, WASHING YOUR HANDS, AND NOT SPENDING A LOT OF TIME IN CROWDED INDOOR SPACES. >> FOR THOSE UNVACCINATED, THE SAFETY DEPENDS ON HOW MUCH COMMUNITY TRANSMISSION IS HAPPENING. AS THAT GOES DOWN, EVERYTHING GETS SAFER. >> IF THE COMMUNITY TRANSMISSION GOES DOWN REALLY LOW, IT’S REALLY LIKELY FOR THERE TO BE A VIRUS THEY COULD BE INFECTED WITH. >> IS MORE ADULTS GET VACCINATED, THAT BECOMES MORE LIKELY. EXPERTS SAY, YES, YOU CAN DO MORE THINGS WITH YOUR KIDS, BUT UNTIL THERE IS A VACCINE FOR THEM, DON’T THROW CAUTION TO THE WIND. >> I THINK THAT MAYBE WE CAN BE LESS SCARED, BUT STILL ADHERE TO OUR PUBLIC HEALTH GUIDANCE AND ADHERE TO THE SCIENCE AND THE RESEARCH THAT GUIDES US TO DO THE RIGHT THINGS. KIM: DOCTORS HOPE THERE WILL BE A VACCINE APPROVED FOR KIDS AGES 12 AND UP BY THE SUMMER.

Commercial

Johnson & Johnson testing COVID-19 vaccine on teenagers

Above video: Docs clarify tips on how to hold younger children protected till vaccine is approvedJohnson & Johnson says it’s testing its single-dose COVID-19 vaccine in teenagers.The corporate will begin by including 16 and 17-year-olds to its Section IIa trials, which have been ongoing since September.It is going to then add a bigger group of youthful adolescents as soon as the info is reviewed.The trial is enrolling individuals within the U.Okay. and Spain with plans to broaden to the U.S., Canada and the Netherlands.The information comes two days after Pfizer introduced its vaccine is 100% efficient in 12- to 15-year-olds.Thus far, the Meals and Drug Administration has not granted emergency authorization for any vaccine in these beneath 16. 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

Above video: Docs clarify tips on how to hold younger children protected till vaccine is authorised

Johnson & Johnson says it’s testing its single-dose COVID-19 vaccine in teenagers.

Commercial

The corporate will begin by including 16 and 17-year-olds to its Section IIa trials, which have been ongoing since September.

It is going to then add a bigger group of youthful adolescents as soon as the info is reviewed.

The trial is enrolling individuals within the U.Okay. and Spain with plans to broaden to the U.S., Canada and the Netherlands.

The information comes two days after Pfizer introduced its vaccine is 100% efficient in 12- to 15-year-olds.

Thus far, the Meals and Drug Administration has not granted emergency authorization for any vaccine in these beneath 16.

Leave a Reply

Your email address will not be published. Required fields are marked *

38  −    =  29